[go: up one dir, main page]

MX340924B - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
MX340924B
MX340924B MX2013012975A MX2013012975A MX340924B MX 340924 B MX340924 B MX 340924B MX 2013012975 A MX2013012975 A MX 2013012975A MX 2013012975 A MX2013012975 A MX 2013012975A MX 340924 B MX340924 B MX 340924B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
pharmaceutical solution
ethanol
propellant
drug
Prior art date
Application number
MX2013012975A
Other languages
English (en)
Other versions
MX2013012975A (es
Inventor
Corr Stuart
James Noakes Timothy
Original Assignee
Mexichem Amanco Holding Soc Anónima De Capital Variable
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexichem Amanco Holding Soc Anónima De Capital Variable filed Critical Mexichem Amanco Holding Soc Anónima De Capital Variable
Publication of MX2013012975A publication Critical patent/MX2013012975A/es
Publication of MX340924B publication Critical patent/MX340924B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una solución farmacéutica para un aparato de suministro de la medicación, especialmente un inhalador de dosis medida. La solución farmacéutica comprende: (a) un componente propulsor licuado que consiste esencialmente de, y que consiste completamente de manera preferible de 1,1-difluoroetano (R-152a); (b) etanol; y (c) un componente farmacéutico disuelto en la mezcla del propulsor/etanol que consiste de al menos un fármaco seleccionado del grupo que consiste de dipropionato de beclometasona (BDP) y propionato de fluticasona (FP).
MX2013012975A 2011-05-13 2012-05-11 Composiciones farmaceuticas. MX340924B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1108039.7A GB201108039D0 (en) 2011-05-13 2011-05-13 Compositions
PCT/GB2012/051059 WO2012156711A1 (en) 2011-05-13 2012-05-11 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
MX2013012975A MX2013012975A (es) 2013-12-12
MX340924B true MX340924B (es) 2016-08-01

Family

ID=44260493

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012975A MX340924B (es) 2011-05-13 2012-05-11 Composiciones farmaceuticas.

Country Status (12)

Country Link
US (4) US20140234229A1 (es)
EP (1) EP2706987B8 (es)
JP (2) JP5904613B2 (es)
CN (2) CN107252415B (es)
AU (1) AU2012257546C1 (es)
BR (1) BR112013029202B1 (es)
CA (1) CA2835810C (es)
ES (1) ES2541417T3 (es)
GB (1) GB201108039D0 (es)
MX (1) MX340924B (es)
WO (1) WO2012156711A1 (es)
ZA (1) ZA201308208B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
CN112472689B (zh) * 2015-12-04 2023-01-17 墨西哥氟石股份公司 药物组合物
GB2554092A (en) * 2016-09-19 2018-03-28 Mexichem Fluor Sa De Cv Pharmaceutical composition
CN105476961B (zh) * 2015-12-16 2019-01-04 武汉同济现代医药科技股份有限公司 一种丙酸倍氯米松气雾剂及其制备方法
GB2554088A (en) * 2016-09-19 2018-03-28 Mexichem Fluor Sa De Cv Pharmaceautical composition
GB201620519D0 (en) * 2016-12-02 2017-01-18 Mexichem Fluor Sa De Cv Pharmaceutical composition
CN109789151A (zh) * 2016-09-19 2019-05-21 墨西哥氟石股份公司 药物组合物
MX2019003099A (es) * 2016-09-19 2019-06-10 Mexichem Fluor Sa De Cv Composicion farmaceutica.
GB2558191A (en) * 2016-09-19 2018-07-11 Mexichem Fluor Sa De Cv Pharmaceutical composition
EP3515439B1 (en) * 2016-09-19 2021-12-15 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising tiotropium bromide
US11260052B2 (en) * 2016-09-19 2022-03-01 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
EP3915555B1 (en) * 2016-09-19 2023-06-28 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising glycopyrrolate
GB2554091A (en) * 2016-09-19 2018-03-28 Mexichem Fluor Sa De Cv Pharmaceutical composition
US11521518B1 (en) 2017-05-04 2022-12-06 IngMar Medical, Ltd. Airway simulation system
GB201712159D0 (en) * 2017-07-28 2017-09-13 Mexichem Fluor Sa De Cv Pharmaceutical composition
CN112203649A (zh) * 2018-06-07 2021-01-08 金德瓦药物控释有限公司 氟替卡松和维兰特罗制剂以及吸入器
GB2584686A (en) 2019-06-11 2020-12-16 Mexichem Fluor Sa De Cv Methods
IL294804A (en) 2020-01-28 2022-09-01 Chiesi Farm Spa Pressurised metered dose inhalers comprising a buffered pharmaceutical formulation
GEP20247642B (en) 2020-02-20 2024-07-10 Chiesi Farm Spa Pressurised metered dose inhalers comprising buffered pharmaceutical formulation
WO2024157282A1 (en) * 2023-01-24 2024-08-02 Cipla Limited Pharmaceutical compositions of green propellant

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5439670A (en) 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
CA2206782C (en) 1994-12-22 2007-04-03 Astra Aktiebolag Aerosol drug formulations
EP1769819A3 (en) * 1995-04-14 2013-05-22 GlaxoSmithKline LLC Metered dose inhaler for fluticasone propionate
ATE219355T1 (de) * 1997-02-05 2002-07-15 Jago Res Ag Medizinische aerosolformulierungen
NZ503464A (en) * 1997-09-29 2002-05-31 Inhale Therapeutic Syst Perforated microparticles containing a bioactive agent for pulmonary delivery
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
PT1102579E (pt) 1998-08-04 2003-07-31 Jago Res Ag Formulacoes de aerossol medicinais
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
GB2354007B (en) * 1999-09-11 2003-10-22 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
GB2392164B (en) * 1999-09-11 2004-04-07 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
CN1144582C (zh) 2000-11-28 2004-04-07 中国药科大学 治疗呼吸系统疾病的无氟里昂药用气雾剂
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2006004646A1 (en) 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
WO2007020204A2 (en) 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
GB0915106D0 (en) 2009-08-28 2009-10-07 Glaxo Group Ltd Process
WO2012093252A1 (en) 2011-01-06 2012-07-12 Cipla Limited Pharmaceutical composition
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions

Also Published As

Publication number Publication date
US10258568B2 (en) 2019-04-16
AU2012257546B2 (en) 2015-06-18
WO2012156711A1 (en) 2012-11-22
BR112013029202B1 (pt) 2022-04-12
AU2012257546C1 (en) 2015-12-24
EP2706987B1 (en) 2015-04-08
EP2706987B8 (en) 2015-05-27
US10258569B2 (en) 2019-04-16
ZA201308208B (en) 2014-06-25
EP2706987A1 (en) 2014-03-19
BR112013029202A2 (pt) 2017-02-14
US20170027867A1 (en) 2017-02-02
US20190142750A1 (en) 2019-05-16
JP2016138107A (ja) 2016-08-04
AU2012257546A1 (en) 2013-11-28
CN107252415A (zh) 2017-10-17
JP5904613B2 (ja) 2016-04-13
CN103517706A (zh) 2014-01-15
JP6125679B2 (ja) 2017-05-10
MX2013012975A (es) 2013-12-12
CA2835810C (en) 2016-08-09
ES2541417T3 (es) 2015-07-20
US10668018B2 (en) 2020-06-02
JP2014513146A (ja) 2014-05-29
GB201108039D0 (en) 2011-06-29
US20170007701A1 (en) 2017-01-12
CA2835810A1 (en) 2012-11-22
US20140234229A1 (en) 2014-08-21
CN107252415B (zh) 2020-08-11

Similar Documents

Publication Publication Date Title
MX340924B (es) Composiciones farmaceuticas.
MX2014004279A (es) Composiciones que comprenden sulfato de salbutamol.
TW201129359A (en) Pharmaceutical composition for the treatment of COPD
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
WO2015054124A3 (en) Dry powder inhaler
AR098982A1 (es) Composición combinada de bromuro de glicopirronio y formoterol en solución estable presurizada para aerosol
MX370890B (es) Composición que comprende sulfato de salbutamol.
WO2011076841A3 (en) Combination therapy for copd
AR123674A2 (es) Composición farmacéutica en aerosol de formoterol y dipropionato de beclometasona
MX2021006751A (es) Inhalador de polvo seco con propionato de fluticasona y xinafoato de salmeterol.
GB201118188D0 (en) Manufacture of medicinal aerosol canisters
HRP20140550T1 (hr) Aerosolna formulacija za copd
WO2012040228A3 (en) Aerosol composition for administering drugs
MX2015015132A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
NZ599900A (en) Pharmaceutical suspension aerosol formulations for use in metered dose inhalers
NZ591174A (en) Metered dose inhaler
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.
BR112012008983A2 (pt) "formulação medicinal em suspensão, composição farmacêutica, produto, uso de cromolina sódica,e, método para aumentar a estabilidade de uma formulação medicinal em suspensão de aerossol."
JP2004529108A5 (es)
RU2014104996A (ru) Способ получения дозирующего распыляющего ингалятора для лечения респираторного заболевания
MY187442A (en) A pharmaceutical composition containing budesonide and formoterol
PE20240807A1 (es) Composiciones, metodos y sistemas para la administracion de farmacos en aerosol
PL432374A1 (pl) Nowy inhalacyjny system terapeutyczny dostarczający zredukowaną ilość propionianu flutikazonu i salmeterolu o zwiększonej skuteczności i profilu bezpieczeństwa
AR103475A1 (es) Un medicamento inhalable
MY191295A (en) Pharmaceutical composition containing budesonide and formoterol

Legal Events

Date Code Title Description
FG Grant or registration